Datopotamab Deruxtecan
Showing 76 - 80 of 80
Breast Cancer, Urothelial Carcinoma Trial in Worldwide (Trastuzumab deruxtecan, Nivolumab)
Active, not recruiting
- Breast Cancer
- Urothelial Carcinoma
- Trastuzumab deruxtecan
- Nivolumab
-
Santa Monica, California
- +28 more
Aug 11, 2021
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Trial in Worldwide (Giredestrant, Abemaciclib,
Recruiting
- Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
- Giredestrant
- +9 more
-
Duarte, California
- +27 more
Jan 31, 2023
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (DS-8201a)
- +5 more
-
Chandler, Arizona
- +207 more
Jan 25, 2022
Breast Cancer Trial in East Melbourne, Seoul (Placebo, Venetoclax, Trastuzumab emtansine)
Terminated
- Breast Cancer
- Placebo
- +2 more
-
East Melbourne, Victoria, Australia
- +2 more
Oct 8, 2021